Baseline profiles of subjects randomised in RESPIRE 2 trial of ciprofloxacin dry powder for inhalation (DPI) in non-CF bronchiectasis (NCFB) by pathogen and prior exacerbation rate

  • Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, Anthony De Soyza, Stuart Elborn, Elaine Montegriffo, Elisabeth Operschall, Eva Polverino, Kevin Winthrop, Robert Wilson
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.pa1555

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1183/13993003.congress-2016.pa1555

In partnership with:

Link to European Respiratory Society (ERS) showcase